These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7225713)

  • 1. Haemodynamic effects of sulphinpyrazone in experimental myocardial ischaemia.
    Russell DC
    Br J Pharmacol; 1981 Jan; 72(1):5-7. PubMed ID: 7225713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.
    Eller BT; Lynch JJ; Patterson E; Lucchesi BR
    Pharmacology; 1987; 34(2-3):121-30. PubMed ID: 3108907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective effect of sulphinpyrazone against coronary occlusion-induced shortening of myocardial refractory periods in the rat.
    Northover BJ
    Br J Pharmacol; 1986 May; 88(1):141-8. PubMed ID: 3708212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lidoflazine in the early stages of acute myocardial ischaemia.
    Coker SJ; Fagbemi O; Parratt JR
    Br J Pharmacol; 1982 Jun; 76(2):347-54. PubMed ID: 7093589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
    Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
    Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of sulphinpyrazone on exercise responses in normal subjects.
    Forfar JC; Russell DC; Oliver MF
    Lancet; 1980 Oct; 2(8197):718-20. PubMed ID: 6106828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct protective effect of sulphinpyrazone on ischaemic and reperfused rat hearts.
    Karmazyn M
    Br J Pharmacol; 1984 Sep; 83(1):221-6. PubMed ID: 6487890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of ranitidine and cimetidine during acute myocardial ischaemia in anaesthetized dogs.
    Dai S
    Agents Actions; 1986 Oct; 19(1-2):26-33. PubMed ID: 2879430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of timolol on arrhythmias and prostanoid release during canine myocardial ischaemia and reperfusion.
    Coker SJ; Parratt JR
    Br J Pharmacol; 1984 Apr; 81(4):675-84. PubMed ID: 6547068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
    Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
    Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
    Vegh A; Szekeres L; Parratt J
    Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative investigations on the antiarrhythmic and electrophysiologic effects of class I-IV antiarrhythmic agents following acute coronary artery occlusion.
    Thale J; Haverkamp W; Hindricks G; Gülker H
    Eur Heart J; 1987 Oct; 8 Suppl G():91-8. PubMed ID: 3443133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pindolol on neurosympathetic responsiveness, blood flow variability, and conduction in acutely ischaemic myocardium: the importance of heart rate.
    Forfar JC; Riemersma RA; Russell DC; Oliver MF
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):153-61. PubMed ID: 2441165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine effects in severe myocardial ischaemia in the dog due to left anterior descending coronary occlusion with left circumflex coronary artery constriction.
    Szekeres L; Udvary E; Végh A
    Br J Pharmacol; 1987 May; 91(1):127-37. PubMed ID: 3594071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium nitrite on ischaemia and reperfusion-induced arrhythmias in anaesthetized dogs: is protein S-nitrosylation involved?
    Kovács M; Kiss A; Gönczi M; Miskolczi G; Seprényi G; Kaszaki J; Kohr MJ; Murphy E; Végh Á
    PLoS One; 2015; 10(4):e0122243. PubMed ID: 25909651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart.
    Raeder EA; Verrier RL; Lown B
    Am J Cardiol; 1982 Aug; 50(2):271-5. PubMed ID: 7102558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
    Vegh A; Papp JG; Parratt J
    Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioning.
    György K; Végh A; Rastegar MA; Papp JG; Parratt JR
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):481-8. PubMed ID: 11101195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
    Smiseth OA; Platou ES; Refsum H; Mjøs OD
    Cardiovasc Res; 1981 Dec; 15(12):724-30. PubMed ID: 7326689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.